Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
The Run-Up Trade: Biodel's Insulin Trial Results
TheStreet.com
Thu, 05/30/13 - 09:01 am
insulin
diabetes
Biodel
BIOD-123
MannKind
Afrezza
Diabetes Drug From Bristol and Astra Wins U.K. Panel’s Backing
Bloomberg
Thu, 05/30/13 - 08:56 am
diabetes
Bristol-Myers Squibb
AstraZeneca
UK
Forixga
Controversial Analysis Of Disputed Trial Finds Avandia Is Safe, After All
Pharmalot
Wed, 05/29/13 - 04:46 pm
GSK
Avandia
diabetes
Spinning RECORD: Battle Over Avandia Heats Up Two Weeks Before Crucial FDA Meeting
Forbes
Fri, 05/24/13 - 11:08 am
Avandia
type 2 diabetes
diabetes
GSK
FDA
Steve Nissen
Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia Comment Now Follow Comments
Forbes
Fri, 05/24/13 - 11:09 am
Steve Nissen
GSK
Avandia
type 2 diabetes
diabetes
Strong Drug Performance Boosts Santarus Higher
Forbes
Fri, 05/24/13 - 10:48 am
Santarus
Cycloset
diabetes
type 2 diabetes
Steve Nissen: The FDA Meeting On Avandia Will Be A 'Whitewash'
Pharmalot
Thu, 05/23/13 - 10:51 am
FDA
Avandia
Steve Nissen
GSK
diabetes
MannKind's Afrezza And The Oramed Threat
Seeking Alpha
Thu, 05/23/13 - 10:29 am
MannKind
Afrezza
diabetes
Oramed Pharmaceuticals
ORMD-0801
Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulin
Seeking Alpha
Mon, 05/20/13 - 09:54 am
Oramed Pharmaceuticals
diabetes
insulin
Roche exploring sale of diabetes device unit
Yahoo/Reuters
Wed, 05/15/13 - 05:14 pm
Roche
devices
diabetes
blood glucose monitoring
Baby Boomers Are Money-Making Machines For Big Pharma
Seeking Alpha
Tue, 05/14/13 - 09:13 am
Merck
JNJ
Pfizer
diabetes
3 Drug Catalysts to Watch in 2013
Motley Fool
Fri, 05/10/13 - 08:58 am
MannKind
Merck
Pfizer
Sanofi
Rigel Pharmaceuticals
suvorexant
insomnia
diabetes
Afrezza
fostamatinib
rheumatoid arthritis
Victoza weight-loss nod could rescue Novo from Tresiba delay, CEO says
Fierce Pharma
Thu, 05/9/13 - 09:48 am
Novo Nordisk
Victoza
Tresiba
diabetes
Lilly broadens diabetes offer with eye on bigger slice of booming market
Reuters
Fri, 05/3/13 - 12:53 pm
diabetes
Eli Lilly
Merck buddies up to Scripps spinout Abide in $430M diabetes partnership
Fierce Biotech
Thu, 05/2/13 - 10:55 am
Scripps Health
Merck
diabetes
Abide
Takeda Gets $6.5 Million Diabetes-Drug Verdict Thrown Out
Bloomberg
Thu, 05/2/13 - 10:38 am
diabetes
Takeda
Actos
bladder cancer
What The Pfizer-Merck Diabetes Deal Teaches About Today's Pharma R&D
Forbes
Tue, 04/30/13 - 08:15 am
Pfizer
Merck
diabetes
ertugliflozin
R&D
Jury hits Takeda with $6.5M judgment in first Actos liability case
Fierce Pharma
Mon, 04/29/13 - 12:59 pm
Actos
Takeda
bladder cancer
diabetes
Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership
TheStreet.com
Mon, 04/29/13 - 11:48 am
Merck
Pfizer
Lexicon Pharmaceuticals
diabetes
ertugliflozin
LX4211
Merck, Pfizer to jointly develop diabetes drug
Reuters
Mon, 04/29/13 - 10:48 am
Merck
Pfizer
diabetes
ertugliflozin
Pages
« first
‹ previous
…
71
72
73
74
75
76
77
78
79
…
next ›
last »